{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:45:33Z","timestamp":1792431933462,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11655-023-3745-6","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T14:02:38Z","timestamp":1692367358000},"page":"311-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice"],"prefix":"10.1007","volume":"30","author":[{"given":"Lea Ling-Yu","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Chung-Lap","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Gar-Lee","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon Sze-Man","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda Sin-Man","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Bik-San","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Chung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kwok","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"3745_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209\u2013249.","journal-title":"CA Cancer J Clin"},{"key":"3745_CR2","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41467-018-03915-4","volume":"9","author":"T Wang","year":"2018","unstructured":"Wang T, Wang D, Yu H, Feng B, Zhou F, Zhang H, et al. A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors. Nat Commun 2018;9:1532.","journal-title":"Nat Commun"},{"key":"3745_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jbi\/wbaa110","volume":"3","author":"KS Johnson","year":"2021","unstructured":"Johnson KS, Conant EF, Soo MS. Molecular subtypes of breast cancer: a review for breast radiologists. J Breast Imaging 2021;3:12\u201324.","journal-title":"J Breast Imaging"},{"key":"3745_CR4","doi-asserted-by":"publisher","first-page":"117955491879056","DOI":"10.1177\/1179554918790563","volume":"12","author":"H Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves H, Guerra MR, Duarte Cintra JR, Fayer VA, Brum IV, Bustamante Teixeira MT. Survival study of triple-negative and non-triple-negative breast cancer in a Brazilian cohort. Clin Med Insights Oncol 2018;12:1179554918790563.","journal-title":"Clin Med Insights Oncol"},{"key":"3745_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity 2013;39:1\u201310.","journal-title":"Immunity"},{"key":"3745_CR6","doi-asserted-by":"publisher","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","volume":"11","author":"W Jiang","year":"2021","unstructured":"Jiang W, He Y, He W, Wu G, Zhou X, Sheng Q, et al. Exhausted CD8+ T cells in the tumor immune microenvironment: new pathways to therapy. Front Immunol 2021;11:622509.","journal-title":"Front Immunol"},{"key":"3745_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol 2020;11:940.","journal-title":"Front Immunol"},{"key":"3745_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-3-319-68864-0_60","volume-title":"Drug discovery and evaluation: methods in clinical pharmacology","author":"AC Marshall","year":"2020","unstructured":"Marshall AC. Traditional Chinese medicine and clinical pharmacology. In: Hock F, Gralinski M, eds. Drug discovery and evaluation: methods in clinical pharmacology. London: Springer Nature;2020:455\u2013482."},{"key":"3745_CR9","doi-asserted-by":"publisher","first-page":"e19567","DOI":"10.1097\/MD.0000000000019567","volume":"99","author":"X Li","year":"2020","unstructured":"Li X, Li X, Liu Q, Sun N, Zhang B, Shi C, et al. Traditional Chinese medicine combined with Western medicine for the treatment of secondary pulmonary tuberculosis: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 2020;99:e19567.","journal-title":"Medicine (Baltimore)"},{"key":"3745_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13020-019-0250-0","volume":"14","author":"KM Lau","year":"2019","unstructured":"Lau KM, Yue GG, Chan YY, Kwok HF, Gao S, Wong CW, et al. A review on the immunomodulatory activity of Acanthopanax senticosus and its active components. Chin Med 2019;14:25.","journal-title":"Chin Med"},{"key":"3745_CR11","first-page":"321","volume":"11","author":"LA Mina","year":"2019","unstructured":"Mina LA, Lim S, Bahadur SW, Firoz AT. Immunotherapy for the treatment of breast cancer: emerging new data. Breast Cancer 2019;11:321\u2013328.","journal-title":"Breast Cancer"},{"key":"3745_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13020-018-0222-9","volume":"13","author":"GGL Yue","year":"2018","unstructured":"Yue GGL, Lee JKM, Chan BCL, Kwok HF, Hoi SWH, Sze DMY, et al. An innovative anti-cancer Chinese herbal formula exhibited multi-targeted efficacies in metastatic breast cancer mouse model. Chin Med 2018;13:64.","journal-title":"Chin Med"},{"key":"3745_CR13","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3390\/molecules26082173","volume":"26","author":"GGL Yue","year":"2021","unstructured":"Yue GGL, Lau CBS, Leung PC. Medicinal plants and mushrooms with immunomodulatory and anticancer properties\u2014a review on Hong Kong\u2019s experience. Molecules 2021;26:2173.","journal-title":"Molecules"},{"key":"3745_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"key":"3745_CR15","doi-asserted-by":"publisher","first-page":"110820","DOI":"10.1016\/j.biopha.2020.110820","volume":"132","author":"Y Fan","year":"2020","unstructured":"Fan Y, Ma Z, Zhao LL, Wang W, Gao M, Jia X, et al. Anti-tumor activities and mechanisms of traditional Chinese medicines formulas: a review. Biomed Pharmacother 2020;132:110820.","journal-title":"Biomed Pharmacother"},{"key":"3745_CR16","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.2147\/OTT.S248797","volume":"13","author":"Y Shi","year":"2020","unstructured":"Shi Y, Kong W, Lu Y, Zheng Y. Traditional Chinese medicine Xiaoai Jiedu Recipe suppresses the development of hepatocellular carcinoma via regulating the microRNA-29a\/signal transducer and activator of transcription 3 axis. Oncotargets Ther 2020;13:7329\u20137342.","journal-title":"Oncotargets Ther"},{"key":"3745_CR17","doi-asserted-by":"publisher","first-page":"731741","DOI":"10.3389\/fphar.2021.731741","volume":"12","author":"W Zhao","year":"2021","unstructured":"Zhao W, Liu J, Li Y, Chen Z, Qi D, Zhang Z. Immune effect of active components of traditional Chinese medicine on triple-negative breast cancer. Front Pharmacol 2021;12:731741.","journal-title":"Front Pharmacol"},{"key":"3745_CR18","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","volume":"2","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Adams S, Disis ML. Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review. JAMA Oncol 2016;2:1354\u20131360.","journal-title":"JAMA Oncol"},{"key":"3745_CR19","doi-asserted-by":"publisher","first-page":"791272","DOI":"10.3389\/fphar.2022.791272","volume":"13","author":"AB Baba","year":"2022","unstructured":"Baba AB, Rah B, Bhat GR, Mushtaq I, Parveen S, Hassan R, et al. Transforming growth factor-beta (TGF-\u03b2) signaling in cancer\u2014a betrayal within. Front Pharmacol 2022;13:791272.","journal-title":"Front Pharmacol"},{"key":"3745_CR20","first-page":"195:22","volume":"15","author":"AVA Mariadoss","year":"2022","unstructured":"Mariadoss AVA, Saravanakumar K, Sathiyaseelan A, Karthikkumar V, Wang MH. Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy. Int J Biol Macromol 2022;15:195:22\u201329.","journal-title":"Int J Biol Macromol"},{"key":"3745_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14786419.2023.2287169","volume":"17","author":"DM Rodrigues","year":"2023","unstructured":"Rodrigues DM, Portapilla GB, de Sicco GS, da Silva IFR, de Albuquerque S, Bastos JK, et al. Novel synthetic derivatives of cinnamic and p-coumaric acids with antiproliferative effect on breast MCF-7 tumor cells. Nat Prod Res 2023;17:1\u201311.","journal-title":"Nat Prod Res"},{"key":"3745_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/jpp\/rgac047","volume":"74","author":"Y Cai","year":"2022","unstructured":"Cai Y, Zhang J, Xin T, Xu S, Liu X, Gao Y, et al. Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses. J Pharm Pharmacol 2022;74:1251\u20131260.","journal-title":"J Pharm Pharmacol"},{"key":"3745_CR23","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.3390\/molecules27113544","volume":"27","author":"R Tohkayomatee","year":"2022","unstructured":"Tohkayomatee R, Reabroi S, Tungmunnithum D, Parichatikanond W, Pinthong D. Andrographolide exhibits anticancer activity against breast cancer cells (MCF-7 and MDA-MB-231 cells) through suppressing cell proliferation and inducing cell apoptosis via inactivation of ER- \u03b1 receptor and PI3K\/AKT\/mTOR signaling. Molecules 2022;27:3544.","journal-title":"Molecules"},{"key":"3745_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13046-018-0926-9","volume":"37","author":"Y Peng","year":"2018","unstructured":"Peng Y, Wang Y, Tang N, Sun D, Lan Y, Yu Z, et al. Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway. J Exp Clin Cancer Res 2018;37:248.","journal-title":"J Exp Clin Cancer Res"},{"key":"3745_CR25","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/carcin\/bgaa090","volume":"41","author":"P Sharma","year":"2020","unstructured":"Sharma P, Shimura T, Banwait JK, Goel A. Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of \u03b2-catenin\/Wnt-signaling pathways in colorectal cancer. Carcinogenesis 2020;41:1385\u20131394.","journal-title":"Carcinogenesis"},{"key":"3745_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.critrevonc.2019.09.003","volume":"143","author":"S Gori","year":"2019","unstructured":"Gori S, Inno A, Belluomini L, Bocus P, Bisoffi Z, Russo A, et al. Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Crit Rev Oncol Hematol 2019;143:139\u2013147.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3745_CR27","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/microorganisms10091727","volume":"10","author":"H Wu","year":"2022","unstructured":"Wu H, Ganguly S, Tollefsbol TO. Modulating microbiota as a new strategy for breast cancer prevention and treatment. Microorganisms 2022;10:1727.","journal-title":"Microorganisms"},{"key":"3745_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/gutjnl-2020-321031","volume":"71","author":"J Huang","year":"2022","unstructured":"Huang J, Liu D, Wang Y, Liu L, Li J, Yuan J, et al. Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy. Gut 2022;71:734\u2013745.","journal-title":"Gut"},{"key":"3745_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.apsb.2021.08.016","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li Q, Liang Y, Zu M, Chen N, Canup BSB, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm Sin B 2022;12:907\u2013923.","journal-title":"Acta Pharm Sin B"},{"key":"3745_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492\u2013506.","journal-title":"Cell Res"},{"key":"3745_CR31","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1158\/1078-0432.CCR-16-0732","volume":"22","author":"ZQ Wang","year":"2016","unstructured":"Wang ZQ, Milne K, Derocher H, Webb JR, Nelson BH, Watson PH. CD103 and intratumoral immune response in breast cancer. Clin Cancer Res 2016;22:6290\u20136297.","journal-title":"Clin Cancer Res"},{"key":"3745_CR32","doi-asserted-by":"publisher","first-page":"3123878","DOI":"10.1155\/2022\/3123878","volume":"2022","author":"X Bai","year":"2022","unstructured":"Bai X, Ta N, Gong GH, Zhang B, Wei CX. Effects of integrated Chinese traditional medicine and conventional Western medicine on the quality of life of breast cancer patients: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2022:2022:3123878.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3745_CR33","doi-asserted-by":"publisher","first-page":"599073","DOI":"10.3389\/fonc.2020.599073","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, So TH, Tang G, Tan HY, Wang N, Ng BFL, et al. Chinese herbal medicine for reducing chemotherapy-associated side-effects in breast cancer patients: a systematic review and meta-analysis. Front Oncol 2020;10:599073.","journal-title":"Front Oncol"},{"key":"3745_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11655-020-3422-y","volume":"27","author":"LN Yang","year":"2021","unstructured":"Yang LN, Wu ZL, Yang ZJ, Li SG, Ouyang CS. Exploring mechanism of key Chinese herbal medicine on breast cancer by data mining and network pharmacology methods. Chin J Integr Med 2021;27:919\u2013926.","journal-title":"Chin J Integr Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-023-3745-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T10:37:08Z","timestamp":1729939028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-023-3745-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3745"],"URL":"https:\/\/doi.org\/10.1007\/s11655-023-3745-6","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"28 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interests. Author Ping-Chung Leung is a member of the Editorial Board for CJIM. The paper was handled by the other editor and has undergone rigorous peer review process. Author Ping-Chung Leung was not involved in the journal\u2019s review of, or decisions related to, this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}